We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Closure System for Laparoscopic Surgery

By HospiMedica staff writers
Posted on 03 Feb 2005
A new closure system is designed to ensure complete wound closure after laparoscopic surgery and prevent postsurgical herniation in obese patients, a common complication among those patients.

Herniation, or a rupture of muscle tissue, is a relatively common complication of laparoscopic surgery, and obese patients have a greater risk of developing hernias at an incision site. More...
Full-thickness closure of the four layers of the abdominal wall prevents this problem. Hand suturing is especially difficult in obese patients, and the new closure system puts full-thickness closure within reach of these patients. Called the Carter-Thomason Closure System XL, the system was named the 2004 Innovative Product of the Year by the Society of Laparoendoscopic Surgeons.

The new system was developed by Inlet Medical, Inc. (Eden Prairie, MN, USA) and is based on the company's Carter-Thomason CloseSure system, which has been marketed since 1998. The number of U.S. bariatric procedures is increasing rapidly. In 2002, 63,000 were performed, of which 15% were laparoscopic. In 2006, an estimated 250,000 procedures will be performed, with 85% completed laparoscopically.

"As the number of obese patients increases, physicians require specialized surgical tools to ensure the best possible outcomes for this challenging patient group,” said Lee Jones, president and CEO of Inlet Medical. "With this surgical system, physicians can close incisions completely, prevent herniation at the site, and improve outcomes without extending surgical time.”





Related Links:
Inlet Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.